Driving innovation in patient-centered healthcare, the Korea Health Industry Development Institute (NECA) opens applications for its 2026 research projects until January 30th. These initiatives aim to enhance public health through patient-focused clinical studies. Designed to generate comparative effectiveness evidence among diverse medical technologies utilized in clinical settings post-approval, these projects are pivotal in linking research findings to clinical practice and health policies, thereby aspiring for a robust and sustainable healthcare system.
Overview of Upcoming Research Endeavors
Since its inception in 2019, this ongoing research initiative has successfully operated under NECA’s guidance as a public interest-focused clinical research R&D project. This endeavor has received substantial support, with a total investment of 1.84 trillion won projected through next year. Through these efforts, the initiative aims to utilize the outcomes of previous research endeavors from Phase 1 (2019-2023), focusing on sequel studies utilizing established databases, alongside research geared towards developing clinical guidelines.
Specific Goals for 2026
For 2026, two main research paths have been highlighted: ‘DB Utilization Follow-up Research’ supported by existing databases, and studies aiming to craft clinical guidelines crucial for the Korean context. This project encourages the integration of research questions and outcomes from both prospective and retrospective studies relevant to the first phase initiatives.
Research projects can be delineated into four categories, totaling 26 new support subjects: nine projects each dedicated to follow-up research utilizing healthcare technology comparison databases, and guideline research, as well as four each for healthcare evidence-generation follow-up research, and guideline studies. The selected projects span one-year terms, with funding capped at 100 million won annually per project.
Observations drawn from past phases underscore the intrinsic value of comparative effectiveness research in informing clinical practice and policy formation. The initiative’s infrastructure’s expansion will significantly aid in broadening patient-centered healthcare research scopes and potential impacts.
As prospective applicants prepare their submissions, they can utilize the government-wide Integrated Research Support System. Applications should be submitted by January 30th, highlighting NECA’s role as a vital contributor in furthering research and development to bolster patient-centric healthcare methodologies. This reinforces NECA’s unwavering commitment to advancing healthcare practices and research capabilities in Korea.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
